SonoSite acquires CardioDynamics
SonoSite, a provider of hand-carried and point-of-care ultrasound systems, has reached an agreement to acquire CardioDynamics International for an aggregate transaction value of approximately $10 million, or $12.3 million net of cash and debt.
The San Diego-based CardioDynamics develops an impedance cardiography (ICG) product line for the non-invasive assessment of cardiac output and other hemodynamic parameters in a physician's office, outpatient clinic or hospital. This information allows physicians to assess and diagnose cardiovascular disorders, target treatment, monitor the effectiveness of prescribed medications and identify potential complications.
The company said its BioZ Dx system integrates ICG with electrocardiography, providing the capability to assess both mechanical and electrical cardiovascular function.
The acquisition is conditioned upon approval by CardioDynamics' shareholders as well as the satisfaction of other customary conditions, according to the Bothell, Wash.-based SonoSite. Approval by SonoSite's shareholders is not required. SonoSite said the transaction is expected to close in the third quarter.
The San Diego-based CardioDynamics develops an impedance cardiography (ICG) product line for the non-invasive assessment of cardiac output and other hemodynamic parameters in a physician's office, outpatient clinic or hospital. This information allows physicians to assess and diagnose cardiovascular disorders, target treatment, monitor the effectiveness of prescribed medications and identify potential complications.
The company said its BioZ Dx system integrates ICG with electrocardiography, providing the capability to assess both mechanical and electrical cardiovascular function.
The acquisition is conditioned upon approval by CardioDynamics' shareholders as well as the satisfaction of other customary conditions, according to the Bothell, Wash.-based SonoSite. Approval by SonoSite's shareholders is not required. SonoSite said the transaction is expected to close in the third quarter.